Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: a meta-analysis

BACKGROUND: Programmed cell death-ligand 1 (PD-L1) may be a useful molecule for targeted immunotherapy. Therefore, this meta-analysis aimed to investigate PD-L1 expression in breast cancer and its associations with clinicopathological factors and outcomes, which may help determine whether PD-L1 expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hye Min, Lee, Jinae, Koo, Ja Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645886/
https://www.ncbi.nlm.nih.gov/pubmed/29041905
http://dx.doi.org/10.1186/s12885-017-3670-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645886/
https://www.ncbi.nlm.nih.gov/pubmed/29041905
http://dx.doi.org/10.1186/s12885-017-3670-1

Ejemplares similares